Last Updated: August 23, 2026

Patent: 5,849,700

✉ Email this page to a colleague

Summary for Patent: 5,849,700

Title:	Pharmaceutical formulation
Abstract:	A pharmaceutical preparation comprising a growth hormone and histidine or a derivative of histidine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved preparation at ambient temperature. Crystallization of growth hormone in the presence of histidine or a derivative thereof gives rise to a higher yield of crystals having a higher purity than known methods.
Inventor(s):	Hans Holmegaard S.o slashed.rensen, Lars Skriver, Annie Rassing Hoelgaard
Assignee:	Novo Nordisk Health Care AG
Application Number:	US08/458,385
Patent Claims:	see list of patent claims

Details for Patent 5,849,700

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	June 20, 2000	⤷ Start Trial	2015-06-02
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	October 01, 2004	⤷ Start Trial	2015-06-02
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	March 10, 2009	⤷ Start Trial	2015-06-02
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	March 01, 2010	⤷ Start Trial	2015-06-02
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	January 23, 2015	⤷ Start Trial	2015-06-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,849,700

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	929825	⤷ Start Trial
World Intellectual Property Organization (WIPO)	9312812	⤷ Start Trial
United States of America	5849704	⤷ Start Trial
United States of America	6022858	⤷ Start Trial
Ukraine	41502	⤷ Start Trial
Slovakia	279641	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.